According to Rigel Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 174,364,000. At the end of 2023 the company had 174,364,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.17 B | 0.88% |
2022 | 0.17 B | 1.04% |
2021 | 0.17 B | 1.2% |
2020 | 0.16 B | 0.85% |
2019 | 0.16 B | 0.56% |
2018 | 0.16 B | 15.55% |
2017 | 0.14 B | 45.74% |
2016 | 98.98 M | 11.17% |
2015 | 89.03 M | 1.42% |
2014 | 87.79 M | 0.42% |
2013 | 87.43 M | 2.53% |
2012 | 85.27 M | 19.72% |
2011 | 71.22 M | 36.64% |
2010 | 52.12 M | 36.69% |
2009 | 38.13 M | 4.25% |
2008 | 36.58 M | 17.89% |
2007 | 31.03 M | 24.18% |
2006 | 24.98 M | 7.54% |
2005 | 23.23 M | 26.37% |
2004 | 18.38 M | 29.26% |
2003 | 14.22 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Amgen AMGN | 535,000,000 | 206.83% | ๐บ๐ธ USA |
AstraZeneca AZN | 3,098,000,000 | 1,676.74% | ๐ฌ๐ง UK |
Sangamo Therapeutics
SGMO | 177,171,000 | 1.61% | ๐บ๐ธ USA |
ChemoCentryx CCXI | 71,234,000 | -59.15% | ๐บ๐ธ USA |